← back to search

Wolfgang C. Winkelmayer­

Baylor College of Medicine · US
Area of research
Nephrology · Hematology
Research interest
Research interests include Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Erythropoietin and Anemia Treatment, and Acute Kidney Injury Research.
h-index
91
citations
30,726
works
670
NIH funding
primary concept
Medicine
email

Recent publications

Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2025cited by 13position: middledoi
#1502 Utilization of telemedicine for patients receiving in-center hemodialysis in the United States
Nephrology Dialysis Transplantation 2025cited by 0position: middledoi
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2024cited by 115position: middledoi
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial
Nature Medicine 2024cited by 43position: middledoi
Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia
Kidney International 2024cited by 14position: middledoi
Patient Perspectives on Using Telemedicine During In-Center Hemodialysis: A Qualitative Study
Kidney Medicine 2024cited by 11position: middledoi
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2023cited by 131position: middledoi
Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2023cited by 113position: middledoi
Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2023cited by 78position: middledoi
Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2023cited by 45position: middledoi
Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis
Nephrology Dialysis Transplantation 2023cited by 12position: middledoi
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients
Kidney Medicine 2023cited by 7position: lastdoi
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial
Circulation 2022cited by 220position: middledoi
Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2022cited by 180position: middledoi
Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease
JAMA 2022cited by 35position: middledoi
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
American Journal of Hematology 2022cited by 22position: lastdoi
Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
American Journal of Nephrology 2022cited by 10position: middledoi
Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
Kidney International 2021cited by 514position: middledoi
Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD
New England Journal of Medicine 2021cited by 237position: middledoi
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Kidney International 2021cited by 208position: middledoi
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis
New England Journal of Medicine 2021cited by 194position: middledoi
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2021cited by 59position: middledoi
Long-Term Exposures to Air Pollution and the Risk of Atrial Fibrillation in the Women’s Health Initiative Cohort
Environmental Health Perspectives 2021cited by 23position: middledoi
Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis
Kidney International Reports 2021cited by 16position: middledoi
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
Kidney International 2020cited by 705position: lastdoi
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2020cited by 562position: middledoi
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Kidney International 2020cited by 539position: middledoi
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2020cited by 253position: middledoi
Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study
American Journal of Kidney Diseases 2020cited by 120position: middledoi
Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach
Annals of Internal Medicine 2020cited by 95position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Glenn M. Chertow · Center for Clinical Research (United States)17 papers (2013–2025)Allison Tong · Brigham and Women's Hospital12 papers (2014–2020)Jonathan C. Craig · Murdoch Children's Research Institute12 papers (2014–2020)Tara I. Chang · Stanford Medicine11 papers (2012–2022)Maria E. Montez‐Rath · Stanford University11 papers (2012–2016)Jenny I. Shen · UCLA Medical Center9 papers (2012–2020)Kevin F. Erickson · Baylor College of Medicine7 papers (2013–2025)Daniel E. Weiner · Tufts Medical Center6 papers (2012–2016)Kai‐Uwe Eckardt · Friedrich-Alexander-Universität Erlangen-Nürnberg6 papers (2020–2023)Brenda R. Hemmelgarn · University of Alberta6 papers (2015–2018)Braden Manns · University of Calgary6 papers (2015–2018)Michel Jadoul · UCLouvain5 papers (2016–2025)David C. Wheeler · Roland Hill (United Kingdom)5 papers (2015–2020)Ravi Thadhani · Woodruff Health Sciences Center4 papers (2019–2024)Wim Van Biesen · University of Manchester4 papers (2015–2018)Candace H. Feldman · Dartmouth College4 papers (2012–2015)Benjamin A. Goldstein · Duke University4 papers (2012–2015)Karen H. Costenbader · Harvard University4 papers (2012–2015)David M. Charytan · NYU Langone Health4 papers (2016–2024)Patrick S. Parfrey · Memorial University of Newfoundland4 papers (2022–2023)